NCT01893060

Brief Summary

Umbilical catheters are necessary for many infants admitted to the Newborn Intensive Care Unit (NICU)and utilized when indicated for up to 7 to 14 days. Bacterial colonization can occur at the umbilical stump and potentially lead to serious bloodstream infections (BSIs). This study is a prospective, randomized controlled feasibility trial to evaluate three types of hygiene products on umbilical line stumps, on the effect of line colonization and subsequent infections. Infants admitted to the NICU with an umbilical line(s) will be randomized into one of four study groups, three products against standard of care (no product). The three products that will be evaluated are currently being used in different capacities for skin care in the University of Virginia (UVA) NICU. The study hypothesizes that twice daily topical application of 1 or more antiseptic to the top of the umbilical stump will decrease colonization of the umbilical stump while umbilical lines are in place.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jul 2013

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 20, 2013

Completed
11 days until next milestone

Study Start

First participant enrolled

July 1, 2013

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 8, 2013

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

August 2, 2013

Status Verified

August 1, 2013

Enrollment Period

10 months

First QC Date

June 20, 2013

Last Update Submit

August 1, 2013

Conditions

Keywords

PrematurityCentral line careUmbilical line colonizationColonizationNewborn Intensive Care UnitNeonatal Intensive Care Unit

Outcome Measures

Primary Outcomes (1)

  • Colonization of umbilical stump

    While umbilical lines are in place, average of 7 days

Secondary Outcomes (2)

  • Late-onset infection

    up to 120 days of life, transfer, death or discharge from NICU

  • Contact dermatitis of cord or skin base

    while lines are in place, average of 7 days

Study Arms (4)

Povidone-Iodine

EXPERIMENTAL

Umbilical stump care. Povidone-Iodine, USP, Swabstick Singles, applied twice a day to cord stump while umbilical line(s) are in place

Drug: Povidone-Iodine

Chlorhexidine

EXPERIMENTAL

Umbilical stump care. ChloraPrep® Chlorhexidine Gluconate 2% w/v; 70% Isopropyl Alcohol v/v Swabstick Single, applied twice a day to cord stump while umbilical line(s) are in place

Drug: Chlorhexidine gluconate

Pluronic Cream

EXPERIMENTAL

Umbilical stump care. Pluronic gel - (F68, Polymyxin, Nystatin, Nitrofurantoin), applied twice a day to cord stump while umbilical line(s) are in place

Drug: Pluronic Cream

Control

SHAM COMPARATOR

No product is applied to cord stump while umbilical line(s) are in place. This is the current standard of care at UVA.

Other: control

Interventions

Povidone-Iodine, USP, Swabstick Singles, applied twice a day to cord stump while umbilical line(s) are in place

Also known as: Betadine
Povidone-Iodine

Chlorhexidine Gluconate 2% w/v; 70% Isopropyl Alcohol v/v Swabstick Single, applied twice a day to cord stump while umbilical line(s) are in place

Also known as: ChloraPrep®
Chlorhexidine

Pluronic cream - (F68, Polymyxin, Nystatin, Nitrofurantoin )applied twice a day to cord stump while umbilical line(s) are in place

Also known as: Pluronic Gel, Pluronic
Pluronic Cream
controlOTHER

No product is applied to cord stump while umbilical line(s) are in place. This is the current standard of care at UVA.

Also known as: Sham control
Control

Eligibility Criteria

AgeUp to 7 Days
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • \*≤7 days of life
  • \*Umbilical line(s) in place (Umbilical arterial catheter=UAC and/or Umbilical venous catheter=UVC)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Virginia HealthSystem

Charlottesville, Virginia, 22932, United States

RECRUITING

MeSH Terms

Conditions

Premature Birth

Interventions

Povidone-Iodinechlorhexidine gluconatePoloxamer

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Intervention Hierarchy (Ancestors)

IodophorsIodine CompoundsInorganic ChemicalsPolyvinylsVinyl CompoundsAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsPovidonePyrrolidinonesPyrrolidinesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsPlasticsPolymersMacromolecular SubstancesBiomedical and Dental MaterialsManufactured MaterialsTechnology, Industry, and AgriculturePolyethylene GlycolsEthylene GlycolsGlycolsAlcohols

Study Officials

  • David A Kaufman, MD

    UVA School of Medicine

    PRINCIPAL INVESTIGATOR

Central Study Contacts

David A Kaufman, MD

CONTACT

Amy E Blackman, BSN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Doctor

Study Record Dates

First Submitted

June 20, 2013

First Posted

July 8, 2013

Study Start

July 1, 2013

Primary Completion

May 1, 2014

Study Completion

July 1, 2014

Last Updated

August 2, 2013

Record last verified: 2013-08

Locations